HSR&D Research Career Scientist Award

高铁

• 批准号: 10392955
• 负责人: MARK A. ILGEN
• 金额: --
• 依托单位: VETERANS HEALTH ADMINISTRATION
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-04-01 至 2024-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10392955
• 关键词: Address; Adverse event; Alcohols; Area; Award; Budgets; Caring; Clinical; Clinical Management; Collaborations; Communities; Databases; Department of Defense; Development; Doctor of Philosophy; Epidemiologist; Evaluation; Family; Funding; Future; Grant; Health; Health Personnel; Health Services; Health Services Research; Homelessness; Improve Access; Institution; International; Intervention; Lead; Leadership; Link; Medical; Mental Health; Mentors; Mentorship; Methods; National Institute of Drug Abuse; Opioid; Outcome; Overdose; Pain; Pain management; Patients; Peer Review; Pharmaceutical Preparations; Physicians; Positioning Attribute; Program Evaluation; Psychologist; Publications; Publishing; Research; Research Design; Research Personnel; Resources; Risk; Risk Factors; Role; Safety; Scientist; Services; Structure; Substance Use Disorder; Suicide; Suicide prevention; System; Testing; Training; Treatment outcome; United States National Institutes of Health; Veterans; Veterans Health Administration; Work; abuse liability; addiction; adverse event risk; behavioral health; brief intervention; career; chronic pain; clinical center; comorbidity; design; evidence base; high risk; implementation study; improved; innovation; member; next generation; opioid epidemic; randomized trial; research and development; severe mental illness; suicidal risk; telehealth

Substance Use Disorders (SUDs) are common in Veterans Health Administration (VHA) patients and are closely linked to some of the most pressing problems facing Veterans including overdose, suicide risk and homelessness. The VHA is a national leader in providing access to high-quality SUD treatment as well as the development of an evidence-base to inform and improve care for Veterans with SUDs. However, key gaps remain, particularly for Veterans who have co-occurring SUDs and psychiatric and/or medical conditions. Nonetheless, there is the clear potential to expand the positive impact of substance- oriented services within the VA by improving access to behavioral health treatments and integrating these services into addictions treatment. Mark Ilgen, Ph.D. has developed a research portfolio focused on tailoring SUD treatment to address patient comorbidity by conducting Veteran-centric health services research on addiction. The two primary thematic aims of this work are: Aim 1: to improve treatment outcomes and reduce risk of adverse events among Veterans with co-occurring SUDs and chronic pain; and, Aim 2: to decrease the risk of suicide among Veterans with SUDs. These two thematic areas directly relate to positive treatment outcomes, as well as reducing the likelihood of adverse events, among Veterans with SUDs. Dr. Ilgen's contributions to these areas are evidenced by his grant-funded research with support from the VA Health Services Research and Development (HSR&D), the Department of Defense and the National Institute on Drug Abuse, in addition to over 165 peer-reviewed scientific publications. Dr. Ilgen has actively mentored nine early career investigators and/or trainees within the VA and has held key administrative positions within the Ann Arbor VA Center of Innovation (COIN), as a member of the leadership team and the co-lead of the Mentorship Core. Given his active and productive research portfolio, as well as his demonstrated commitment to mentoring colleagues in developing VA research careers, Dr. Ilgen is a strong candidate for a Health Services Research Career Scientist Award. The proposed Research Career Scientist Award will support his continued research, as well an expanded role in mentorship and training of the next generation of HSR&D researchers. This research portfolio has the potential to address some of the most-critical and vexing behavioral health-related priorities in VHA and improve care for some of the most challenging and highest-risk Veterans treated within the VHA system.

物质使用障碍（SUD）在退伍军人健康管理局（VHA）患者中很常见， 与退伍军人面临的一些最紧迫的问题密切相关，包括过量服用，自杀风险 和无家可归。VHA是提供高质量SUD治疗的国家领导者， 以及发展证据基础，以告知和改善对患有SUD的退伍军人的护理。 然而，关键的差距仍然存在，特别是对于同时发生SUD和精神和/或 医疗条件。尽管如此，扩大实质性内容的积极影响显然是有潜力的， 通过改善行为健康治疗的可及性，并将这些 成瘾治疗服务。Mark Ilgen博士开发了一个研究组合， 通过开展以退伍军人为中心的卫生服务，定制SUD治疗以解决患者并发症 关于成瘾的研究这项工作的两个主要专题目标是：目标1：改善治疗 结果和降低退伍军人中并发SUD和慢性疼痛的不良事件风险; 目标2：降低SUD退伍军人的自杀风险。这两个主题领域直接 与积极的治疗结果有关，以及减少不良事件的可能性， 有SUD的退伍军人伊尔根博士对这些领域的贡献是由他的赠款资助的研究证明 在VA卫生服务研究与发展（HSR&D）的支持下， 国防部和国家药物滥用研究所，除了超过165个同行评审的科学 出版物。Ilgen博士积极指导了VA内的9名早期职业调查员和/或学员 并曾在安阿伯VA创新中心（COIN）担任重要行政职务， 领导团队成员和指导核心的共同领导。鉴于他的积极和富有成效的 研究组合，以及他对指导同事发展VA的承诺 研究职业，博士伊尔根是一个健康服务研究职业科学家奖的有力候选人。 拟议的研究职业科学家奖将支持他继续研究，以及扩大 在指导和培训下一代HSR&D研究人员方面发挥作用。该研究组合具有 解决VHA中一些最关键和最令人烦恼的行为健康相关优先事项的潜力 并改善对VHA内治疗的一些最具挑战性和最高风险的退伍军人的护理 系统